Materials and Reagents: All the chemicals used were analytical reagent (AR) degrade. Copper nitrate (Cu(NO 3 ) 2 ), L-cysteine (Cy), sodium sulfide, folic acid (FA), 1-(3dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC), N-Hydroxysuccinimide (NHS), doxorubicin (DOX), 3-4,5-dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide (MTT), and anhydrous ethanol are analytically pure and were purchased from Aladdin Chemical Reagent Co. (Shanghai, China). NHS-Flurosecein, dimethyl sulfoxide (DMSO), 3′,6′-Di(O-acetyl)-4′,5′bis[N,N-bis(carboxymethyl) aminomethyl] fluorescein (Calcein AM), propidium iodide (PI) and 2-(N-Morpholino)ethanesulfonic acid (MES) were purchased from Sigma (St Louis, USA). Other reagent are all analytical pure from Aladdin Chemical Reagent Co. (Shanghai, China).
was then stirred in the dark for 2 h. 20 mL Cu 39 S 28 NPs solution (1 mg/mL) was added and allowed to react for 12 h under room temperature. The FA-conjugated Cu 39 S 28 nanocomposites were separated by centrifugation at 10 000 rpm for 10 min and washed with DMSO and deionized water three times separately. Then the nanocomposites were stored in 4 o C for consequent use.
Drug loading and release test: 5 mg Cu 39 S 28 NPs was added to 5 mL PBS (pH 7.4) and dispersed by ultrasonication. After that, 5 mg DOX was added into the solution with slow stirring at room temperature for 24 h. The as-prepared mixture was centrifugally separated at 8, 000 rpm for 5min and washed 3 times with PBS solution to remove the free drug, the supernatant solution containing DOX was measured at 482 nm by a UV-VIS spectrophotometer. Encapsulation efficiency % = Weight of drug loaded into the NPs/ Initial weight of drug; Loading content % = (Weight of drug loaded into the NPs) / (Weight of NPs + Weight of drug loaded into the NPs).
The DOX release from Cu 39 S 28 HNPs was performed by dispersing 5 mg Cu 39 S 28 /DOX nanocomposites in 5 mL PBS solution (pH 5, 7) with stirring in 37 o C and room temperature respectively. The Cu 39 S 28 /DOX solutions were centrifuged at every pointed time, and the supernatant solutions were collected. The process was repeated and the pointed time set as 1, 2, 4, 8, 12, 24, 36 and 48 h, separately. With the same process, the DOX release in pH=5 PBS was tested under 808 nm irradiation for 10 min and the laser off in 10-100 min, then the laser was turned on in 100-110 min for another 10 min. The release percentage of DOX in the solution was analyzed at the wavelength of 482 nm by spectrophotometer.
Characterization: Optical absorption spectra of the samples were measured with a spectrophotometer (Perkin Elmer, USA) working in a spectral range from 200 to 1000 nm. The crystalline structure, size and shape of the nanoparticles were observed by X-ray diffraction (XRD) and high-resolution transmission electron microscopy (HRTEM). XRD was measured using a Siemens Kristalloflex 810 D-500 X-ray diffractometer (Karslruhe, Germany) under an operating mode of 40 kV and 30 mA, with λ = 1.5406 Å radiation. Cu 39 S 28 HNPs in solution were placed onto holey carbon-covered copper grids for HRTEM observation. The HRTEM images of the particles were obtained with a Hitachi 2100 electron microscope with accelerating voltage of 300 KV. Fourier Transform Infrared Spectroscopy (FTIR) spectra were measured on a IR spectrophotometer (Vertex 70, German) using the KBr pellet technique. N 2 adsorption/desorption isotherms were obtained on a Micromeritics ASAP Tristar II 3020 apparatus. Zeta potential measurements were determined with the Zetasizer Nano Z (Malvern, UK). UV-Vis absorption spectra were measured by the multifunctional microplate reader (Thermo,USA). Pore size distribution was calculated by the Barrete-Jonere-Halenda (BJH) method. The X-ray photoelectron spectroscopy (XPS) experiments S-3 were carried out on a Thermao Escalab 250 system using Al Kα radiation, the binding energies were calibrated by referencing the C 1s peak (284.6 eV) to reduce the sample charge effect. The samples used for analysis were washed with distilled water and ethanol each for three times, respectively, and then dried under dynamic vacuum at 60 o C for 3h.
Proliferation:
The viability of Cu 39 S 28 and Cu 39 S 28 -FA nanoparticles on MCF-7 cells (purchased from the Type Culture Collection of the Chinese Academy of Sciences) was characterized by using MTT assay. Briefly, cells were seeded onto the substrates at a density of 1×10 4 cells per cm 2 and cultured in 37 o C for 12 h. Then gradient concentrations of 0, 15.6, 31.2, 62.5, 125, 250, 500 , 1000 μg/mL Cu 39 S 28 HNPs and Cu 39 S 28 -FA were added to the plates, after cocultured for 24 h, 10 μL of MTT solution (5 mg/mL in PBS) was added to 100 μL culture medium and incubated for 4 h at 37 o C. Subsequently, the medium was removed, the formazan reaction products were dissolved in 100 μL DMSO for another 5 min. The optical density of the formazan solution was read using a microplate reader (Thermo, Multiskn Go) at 490 nm.
Chemo-photothermal therapy in vitro: MCF-7 cells (1×10 4 /mL, 100 μL) were plated into a 96-well plate in a complete medium for 24 h before the experiments. The culture medium was discarded and replaced with a complete medium containing DOX, Cu 39 S 28 /DOX NPs, Cu 39 S 28 -FA/DOX NPs and cultured for another 6 h. After the incubation, the cells were washed with PBS and replaced with fresh medium. The cells were irradiated with or without 808 nm laser (1W/cm 2 ) for 10 min, and were then incubated for a further 24 h. The standard MTT assay was carried out to determine the cell viabilities relative to the control untreated cells.
Hemocompatibility Tests: The hemocompatibility was evaluated by hemolysis ratio. Red blood from healthy human containing sodium citrate (3.8 wt. %) was diluted to 4/5 with PBS (pH=7.4). Diluted blood cells (0.5 mL) were then mixed with 4.5 mL deionized water as a positive control; 4.5 mL PBS as a negative control; 4.5 mL Cu 39 S 28 materials suspensions with varying concentrations (400, 100, 25,6.25 μg/mL). Then the samples were shaken and kept stable in 37 o C for 2 h, the tubes were centrifuged at 3000 rpm for 5 min, and the optical density (OD) values of the supernatant placed in a 96-well plate was determined on an ELISA plate reader (Thermo, USA) at a wavelength of 545 nm. The hemolysis rate (HR) was calculated as follows by Eq. based on the average of three replicates:
Live/Dead staining: For viability staining studies, Cells were seeded on 96-well plates at a concentration of 5 × 10 4 cells/cm 2 at 37 °C with 5 % CO 2 for 24 h. 100 μL optimum concentration of nanoparticles (Cu 39 S 28 , Cu 39 S 28 -FA, Cu 39 S 28 /DOX, Cu 39 S 28 -FA/DOX, free DOX ) with 25μg/mL DOX were added to the plate, then irradiated with or without 808 nm laser at density of 1 W/cm 2 for 10 min, the medium was removed and the adherent cells were subjected to Live/Dead staining following the manufacturer's protocol (Sigma, USA). Briefly, after the removal of the culture medium, the cells were rinsed once in PBS, followed by addition of 100 μL PBS containing 1 μM S-4 calcein AM and 2 μM PI. Cells were then photographed using a fluorescence microscope (Olympus, BX51, Japan).
Cell apoptosis and necrosis:
The MCF-7 cells suspension (400 μL) was seeded on a 24-well cell culture plate, at a density of 1 ×10 5 cells/mL. After 24 hours, Cu 39 S 28 , Cu 39 S 28 -FA, Cu 39 S 28 /DOX, Cu 39 S 28 -FA/DOX, free DOX were added to the plate, then treated with (or without) laser for 10 min. To analyze the changes in the nuclear morphology, MCF-7 cells were tested using Guava Nexin Reagent (Millipore, USA). Brefily: Cells on the substrates were washed with PBS and centrifuged at 1000 rpm for 5 min. The cell pellets were resuspended in 100 μL DMEM medium supplemented with 1% FBS, and then incubated with 100 μL of Annexin V-PE and 7-AAD labelling solution for 20 min at room temperature. Cells were finally analyzed with a Guava EasyCyte 5HT In vivo targeting and biodistribution : A suspension of 1 × 10 7 MCF-7 cells was injected subcutaneously into the bakc of nude mice. When tumors grew to 5~7 mm in diameter, the MCF-7 bearing nude mice were randomly divided into 3 groups with each of 5 mice: 1) PBS (50 μL), 2) Cu 39 S 28 nanocomposites (50 μL, 20 mg/kg ) 3) Cu 39 S 28 -FA nanocomposites (50 μL, the same amount of Cu 2+ with group 2) through intravenous (i.v.) injection. After 24 h, mice were killed and the distribution of Cu 2+ in brain, heart, liver, spleen, lung, kidney, muscles and tumor were tested using ICP-MS method . The main organs were weighed, then 5 mL HCl: HNO 3 (3:1) added to the each sample and digested at 60 o C for 30 min, then tranfered to the flask for testing, a series of standard Cu 2+ standard solutions (0, 0.5, 1, 5, 10, 20, 50, and 100 ppm) were prepared. Both standard and test solutions were measured by ICP-MS (Thermal Fisher Scientific Inc., USA). And the amount of Cu 2+ in main organs, muscles and tumor site were compared.
S-5
Evaluation of the Chemo/photothermal Effects in Mice: Mice bearing breast tumors were randomly divided into seven treatment groups with each of 5 mice and injected via tail vein with: 1) PBS (50 μL); 2) PBS+NIR ; 3) DOX (50 μL, 2 mg/kg); 4) Cu 39 S 28 -FA (50 μL, 2 mg/kg); 5) Cu 39 S 28 -FA/DOX (50 μL, 2mg/kg); 6) Cu 39 S 28 -FA (50 μL, 2 mg/kg) + NIR, 7) Cu 39 S 28 -FA/DOX (50 μL, 2 mg/kg) +NIR . After 120 min, the tumors were irradiated with or without NIR light (808 nm, 1 W/cm 2 , 10 min). Tumor size and body weight were recorded with a caliper and electronic scales every other day for two weeks, separately. The tumor volume was calculated by the following formula: V = (L × W 2 )/2, where L and W are the longest and shortest tumor dimensions respectively.
Hematoxylin and eosin (H&E) Staining:
After the treatments, mouse organs including heart, liver, spleen, lung, kidney, and tumor were collected and fixed in 4% paraformaldehyde overnight in 4 °C. The H&E staining was performed following a standard protocol. Briefly, tissue samples were embedded in paraffin blocks, sectioned into 5 μm slices, mounted onto the glass slides, and stained with hematoxylin and eosin stains. All slices from different treatment groups were blindly processed. Images of the main organs sections stained by H&E were visualized with a fluorescence microscope.
Statistical analysis：All statistical analysis was performed by analysis of variance (ANOVA) using SPSS 13.0. The results were considered statistically significant if the p-value was <0.05
Photothermal Conversion: Following a previous method 1 the photothermal conversion efficiency (η) of the Cu 39 S 28 HNPs was measured. The aqueous solution of the Cu 39 S 28 HNPs (250 ppm) was under continuous irradiation of the laser (808 nm, 1 W/ cm −2 ) until a steady state temperature was reached. Subsequently, the laser was shut off, and the temperature decrease of the aqueous solution was recorded to measure the rate of heat transfer from the Cu 39 S 28 HNPs solution system to the environment (Figure 3a) . The η value was calculated as follows:
where h is the heat transfer coefficient, S is the surface area of the container, and the value of hS was gained from Figure S4 . T max − T Surr is the temperature change of the Cu 39 S 28 HNPs solution at the maximum steady-environmental temperature, I is the power of the laser, A808
is the absorbance of Cu 39 S 28 HNPs at 808 nm, and Q Dis expresses heat dissipated from light absorbed by the solvent and the container. In order to gain hS, a dimensionless parameter θ is introduced as followed:
Substituting Eq.2 into Eq.1 and rearranging Eq.1:
The light source was shut off, the Q NP +Q Dis = 0, reducing the Eq. 3 
Cu 39 S 28 sample reacted with Na 2 S for 60 min, (A4)Cu 39 S 28 sample reacted with Na 2 S for 90 min; (B)TEM images of Cu 39 S 28 samples with different reaction times; Inset: image above is the correspongding SAED and image below is the magnified TEM. (B1) Cu-Cy precusors (without addition of Na 2 S), (B2) Cu 39 S 28 sample reacted with Na 2 S for 30 min, (B3) Cu 39 S 28 sample reacted with Na 2 S for 60 min, (B4) Cu 39 S 28 sample reacted with Na 2 S for 90 min; (C) XPS spectra of Cu- S-8 Cy prescusor without addition of Na 2 S. (C1) XPS spectra of survey; (C2) XPS spectra of Cu 2p; (C3) Cu 2p 2/3 peak fit. The Cu 2p 2/3 peak fit reveals a main peak at 932.2 eV (corresponded to Cu + in Cu(I)cysteine), (C4) XPS spectra of S 2p;
There was almost no peaks in the XRD images ( Figure S2 A1) of the Cu-Cy prescusor, indicating the non-crystal structure of the precursor. After reacted with Na 2 S for 30, 60, 90 min ( Figure S2 A2, A3, A4) , the samples corresponding well with Cu 39 S 28 . In Figure S2 A1 , first a loose and irregular Cu 39 S 28 structure were formed, and amorphous structure were detected by SAED when only with the reaction of Cu(NO 3 ) 2 and L-cysteine. Then after reacted with Na 2 S for 30 min, hollow Cu 39 S 28 structure were formed. With time increased, more clear hollow nanostructure appeared. The 90 min products ( Figure S2 A4) exhibited unique hollow nanopeanuts sctructure.
The XPS results of the former precursors were investigated (without Na 2 S, as shown in Figure  S2 C) . For the reducibility of L-cysteine, the Cu 2P 3/2 showed a main peak at 932.3 eV, which corresponding well with Cu + in Cu(I)cysteine, and the reaction between cupric ions and cysteine was as below: 2 Cu 2+ + HOOCCH(NH 2 )CH 2 SH Cu + + OOCCH(NH 2 )CH 2 S-SCH 2 CH(NH 2 )COOH Cu + + HOOCCH(NH 2 )CH 2 SH HOOCCH(NH 2 )CH 2 S-Cu(I) After reacted with Na 2 S for 90 min, the superfluous Cu 2+ ions were reacted with Na 2 S to form Cu 39 S 28 embracing the initial Cu(I)cysteine, and the final products exhibited 2 peaks at Cu 2p3/2 (as shown in Figure S1 ), the peak at 932.2 eV corresponding to Cu(I)cysteine and the 933.5 eV peak assigned to Cu 2+ in Cu 39 S 28 ( Figure S1 ), corresponding well with the XRD results (Cu 39 S 28 ). 
